Abstract
Introduction
The lasting hypoxic exposure or vigorous exercise could lead to the adaptive cardiac hypertrophy [1, 2] . Unlike the toxic effect of severe hypoxia, mild hypoxia (MH, 10% oxygen) could not induce any cytotoxicity but trigger hypertrophic responses in cultured neonatal rat cardiac myocytes [3] , and the mechanisms involved remain to be elusive. [4] . So far, role of HIF-1␣ in the development of cardiac hypertrophy has been sparsely documented. Silter et al. [5] have shown that HIF-1␣ is critically involved in the preservation of cardiac function without affecting cardiac hypertrophy by using HIF-1␣ knockdown mice with transverse aortic constriction. Recently, Xue et al. [6] have demonstrated that cardiac-specific overexpression of HIF-1␣ could prevent deterioration of glycolytic pathway and cardiac hypertrophy in streptozotocin-induced diabetic mice. More interestingly, carvedilol, a ␤-receptor blocker, has emerged as a beneficial treatment for cardiac hypertrophy and inhibited the overexpression of HIF-1␣ in pressure-overloaded rat heart [7] . These studies regarding the role of HIF-1␣ in cardiac hypertrophy were based upon pathologic situation, and their conclusions were under the controversial arguments. The previous investigations have shown that hypoxia is a critical factor which triggers cardiac hypertrophy in vivo [2, 8] [10] . Kuwahara et al. [11] 
Hypoxia-inducible factor 1 alpha (HIF-1␣) is a heterodimeric subunit of the transcription factor HIF-1, which regulates the transcription of genes involved in adaptive responses to hypoxia

Cell culture and MH
Cardiomyocytes from 1-or 2-day-old Wistar rats were isolated, subjected to Percoll gradient centrifugation and cultured as previously described [13] 
Immunofluorescence
Immunofluorescence was performed as described [15] . 
Patch clamp
Patch clamp is done as previously described [11, 19, 20] . 
Data analysis
Data are presented as the mean Ϯ S.E.M. Differences were evaluated using the unpaired Student's t-test, and P Ͻ 0.05 was considered to be statistically significant. (Fig. S1 ). Figure 3A and B. ␣-actinin (Fig. 3C ) and a statistical graph were shown from cell surface area (Fig. 3D) , Figure 3C showed (Fig. 4C) . Calcineurin expression in hypertrophic cardiomyocytes was also inhibited by SK&F96365 (Fig. 4D) . SK&F96365 also restored p-NFAT expression level, a substrate of calcineurin, induced by MH (Fig. 4E) Figure 4F , MCIP1 mRNA expression was significantly increased in MH exposed cardiomyocytes, and the increased MCIP1 mRNA expression was inhibited by SK&F96365 treatment. These results were consistent with the previous report [22] . In addition, SK&F96365 also prevented MH-induced hypertrophic morphology in cardiomyocytes (Fig. 4G) and blocked MH-induced hypertrophy-related genes expression, for instance, ANP, BNP and ␤-MHC (Fig. 4H) (Fig. 5A ) and protein expression levels ( Fig. 5B and  C) , which could be completely suppressed by HIF-1␣ blocker, SC205346. It also showed that the elevation of [Ca 2ϩ ]i (Fig. 5E ) and enhanced expression of calcineurin (Fig. 5D) (Fig. 6A) and protein (Fig. 6B and C (Fig. 7C) , which was consistent with TRPC current detection in HIF-1␣ transfected cardiomyocytes. 
Results
MH induces hypertrophy in cultured cardiomyocytes of neonatal rats
HIF-1␣ controls development of hypertrophy induced by MH in cardiomyocytes
In order to investigate whether HIF-1␣ participates in the development of hypertrophy, an HIF-1␣ specific blocker, SC205346, for the loss-of-function and HIF-1␣ transfection for the gain-offunction were used before cardiomyocytes exposed to MH. A successful transfection was demonstrated as shown in
) level when compared to NC cells. HIF-1␣ overexpression facilitated [Ca 2ϩ ]i elevation (Fig. 6E) and calcineurin up-regulation (Fig. 6D) by MH in cardiomyocytes. Interestingly, HIF-1␣-overexpressed cardiomyocytes under normal oxygen condition also caused an up-regulation of TRPC3 or TRPC6 protein (Fig. 7C), suggesting a tight regulatory role of HIF-1␣ in TRPC expression.
HIF-1␣ overexpression enhances TRPC current in cardiomyocytes
Fig. 3 HIF-1␣ controls development of hypertrophy in cardiac myocytes under MH. Representative immunofluorescence (A) and immunoblotting (B) for HIF-1␣ showed overexpressed nuclear HIF-1␣ in cardiomyocytes transfected with HIF-1␣ compared to negative control (NC). Cardiomyocytes were transfected with HIF-1␣ at a dose of 8.0 g for 48 hrs. (C) Representative ␣-actinin immunostaining images were taken under different experimental conditions as indicated (original magnification: ϫ600). (D) Statistical bar graph from (C) showed that hypertrophic cardiomyocytes under 6-hr
Fig. 4 MH triggers elevation of TRPC-mediated Ca 2ϩ signals. Bar graphs of TRPC1, TRPC3 and TRPC6 mRNA by real-time PCR (A) and protein expression by Western blotting (B) in cultured neonatal cardiac myocytes under MH condition at the indicated time points. (C) Elevation of [Ca 2ϩ ]i in cardiomyocytes under MH conditions was inhibited by two TRPC channel blockers, 2-APB and SK&F3586. 2-APB (30 M) and SK&F3586 (10 M) were given to cardiomyocytes 1 hr before MH exposure. (D) Enhanced calcineurin in cardiac myocytes cultured under MH conditions was inhibited by SK&F3586. (E) TRPC channel blocker SK&F96365 blocked p-NFAT decrease induced by MH. Total NFAT was not changed under the indicated condition. (F) SK&F96365 blocked MCIP1 mRNA increase induced by MH. (G) SK&F96365 prevented MH-induced cardiomyocytes hypertrophy by ␣-actinin immunostaining (H) SK&F96365 completely inhibited ANP, BNP and ␤-MHC
